This thesis explores the use of metallic bismuth in the form of extremely small particles called nanoparticles, where materials behave differently from their bulk counterparts due to size effects. At the nanoscale, bismuth exhibits unique magnetic, thermal, and optical properties, which can be harnessed for cancer diagnosis and treatment. The current research focused on designing and bio-functionalizing bismuth nanoparticles to make them more stable, biodegradable, and capable of specifically targeting cancer cells. By attaching small targeting molecules, such as peptide epitopes that recognize cancer-associated proteins like fibroblast activation protein (FAP), the nanoparticles were guided specifically to tumour tissue while avoiding healthy cells. In addition, other types of bismuth-based materials, including chalcogenides (such as bismuth oxide nanoparticles) and nanohybrids (i.e. POM decorated bismuth nanoparticles), were developed and characterized, offering potential for use in a broader range of biomedical applications.<p></p>
History
Campus location
Australia
Principal supervisor
Philip Andrews
Additional supervisor 1
Victoria Blair
Year of Award
2025
Department, School or Centre
Chemistry
Course
Doctor of Philosophy
Degree Type
DOCTORATE
Faculty
Faculty of Science
Rights Statement
The author retains copyright of this thesis. It must only be used for personal non-commercial research, education and study. It must not be used for any other purposes and may not be transmitted or shared with others without prior permission. For further terms use the In Copyright link under the License field.